Skip to content

Haloperidol as an antiemetic following abdominal hysterectomy - a comparison with Zofran®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN21871435
Enrollment
Unknown
Registered
2003-09-12
Start date
2001-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post operative antiemetics Surgery Postprocedural disorders of digestive system, not elsewhere classified

Interventions

Prospective randomised trial. 17/09/2012: Please note that this trial was stopped as the trial objectives were no longer viable

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All American Society of Anesthesiologists (ASA) I - III females undergoing abdominal hysterectomy who give their consent.

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026